Results 121 to 130 of about 11,467 (254)
Update on the medical treatment of Graves’ ophthalmopathy
International Journal of General Medicine, 2009 Gregory J Griepentrog, James A GarrityDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USAPurpose: To review recent advances in the understanding of Graves’ ophthalmopathy (GO) pathogenesis as well as discuss current and future medical ...
Gregory J Griepentrog, James A Garrity
doaj
, 2015 El síndrome metabólico es un conjunto de factores de riesgo, que requieren la presencia de obesidad de predominio central, dislipemia, hipertensión arterial y resistencia a la insulina, todos ellos, predictores de enfermedad cardiovascular y diabetes ...
Güemes-Hidalgo, M., Muñoz-Calvo, M. T.
core +1 more source
Abstract #1407112: Assessment of the Thyroid Eye Disease Specific Graves’ Ophthalmopathy Quality of Life Questionnaire in Non-Inflammatory or Inactive Thyroid Eye Disease Patients [PDF]
, 2023 Terry J. Smith +3 more
openalex +1 more source
Hyperthyroid heart disease: Diagnostic and therapeutic aspects [PDF]
, 1990 Reinwein, Dankwart +2 more
core +1 more source
Ocular surface changes in Graves’ ophthalmopathy
, 2021 Rou Sun, Huifang Zhou
openalex +1 more source
Pulsatile ocular blood flow in patients with Graves' ophthalmopathy [PDF]
, 2004 Chieh‐Chih Tsai +6 more
openalex +1 more source
Treatment of graves' ophthalmopathy with cyclosporin a [PDF]
, 1985 A Witte +5 more
openalex +1 more source
TEMPORAL RELATIONSHIP BETWEEN THE ONSET OF THYROID DERMOPATHY AND GRAVES' OPHTHALMOPATHY
Acta Medica Iranica, 1993 Pretibial myxedema is an uncommon manifestation of Graves' disease and because of its rarity, information regarding its natural course and its relationship with other manifestations of Graves' disease is not sufficient.
Mohammad Pajhouhi
doaj